CCL5 and thyroid gland carcinoma: Conversely, one previous study reported significantly lower levels of CCL5/RANTES in 23 thyroid cancer patients (18 patients with PTC) compared to 23 healthy participants, while our study included more participants (63 patients with PTC and 63 healthy participants) [9].